JEOL Ltd
TSE:6951
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 406
7 403
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
JEOL Ltd
Total Current Liabilities
JEOL Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
JEOL Ltd
TSE:6951
|
Total Current Liabilities
ÂĄ83.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
||
Terumo Corp
TSE:4543
|
Total Current Liabilities
ÂĄ231B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
||
Olympus Corp
TSE:7733
|
Total Current Liabilities
ÂĄ419.6B
|
CAGR 3-Years
13%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
||
Sysmex Corp
TSE:6869
|
Total Current Liabilities
ÂĄ107.4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
||
Nihon Kohden Corp
TSE:6849
|
Total Current Liabilities
ÂĄ40.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
||
Fukuda Denshi Co Ltd
TSE:6960
|
Total Current Liabilities
ÂĄ27.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
1%
|
JEOL Ltd
Glance View
In the bustling world of advanced scientific instrumentation, JEOL Ltd. has carved a distinguished niche for itself as a renowned innovator from the Land of the Rising Sun. Founded in 1949, this Japanese trailblazer has unfurled an impressive tapestry of technological advancements in electron optics and analytical instruments. With its headquarters nestled in Tokyo, JEOL has been at the forefront of developing sophisticated tools such as scanning electron microscopes, nuclear magnetic resonance spectrometers, and mass spectrometers. These instruments have become indispensable for scientists and researchers across myriad fields, ranging from materials science to biotechnology. By focusing on high-quality precision and cutting-edge innovation, JEOL's products aid in unveiling the microscopic secrets of the world, empowering its users to explore realms of science once thought unreachable. What sets JEOL apart is its commitment not just to the science of today but to the possibilities of tomorrow. The company has consistently reinvested its profits into research and development, fostering a culture of perpetual innovation. By maintaining a comprehensive global sales and support network, JEOL ensures that its instruments are not only technologically advanced but also accessible to a worldwide clientele. This business model is reflective of their ability to generate revenue through both direct sales and ongoing service and support contracts, ensuring a steady revenue stream while bolstering relationships with research institutions, universities, and industries worldwide. Through this multifaceted approach, JEOL sustains its financial health, while solidifying its reputation as a catalyst for scientific discovery and technological progress.
See Also
What is JEOL Ltd's Total Current Liabilities?
Total Current Liabilities
83.7B
JPY
Based on the financial report for Sep 30, 2024, JEOL Ltd's Total Current Liabilities amounts to 83.7B JPY.
What is JEOL Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%
Over the last year, the Total Current Liabilities growth was 3%. The average annual Total Current Liabilities growth rates for JEOL Ltd have been 8% over the past three years , 7% over the past five years , and 5% over the past ten years .